Answers are grounded in this paper and cite their sources.
Current evidence does not suggest an association between antiresorptive therapy in patients with osteoporosis and dental implant failure. Implants may be safely placed in the presence of concomitant use of bisphosphonates or denosumab in patients with osteoporosis with no evidence of an increased risk of implant failure/compromise.
No takes yet. Share an insight, caveat, or question.
Ali et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: